Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer

Oncology Research

Volumn 18, Issue 11-12, 2010, Pages 583-591

  Kalender, Mehmet E ^a   Demiryürek, Seniz ^a   Oztuzcu, Serdar ^a   Kizilyer, Ayse ^a   Demiryürek, Abdullah T ^a   Sevinc, Alper ^a   Dikilitas, Mustafa ^b   Yildiz, Ramazan ^c   Camci, Celalettin ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Breast carcinoma; Genetic polymorphisms; Metastasis; Rho kinase

Indexed keywords

RHO KINASE; ROCK2 PROTEIN, HUMAN;

ADULT; AGED; BREAST NEOPLASMS; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; METASTASIS; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; POLYMORPHISM, GENETIC; RHO-ASSOCIATED KINASES; RISK FACTORS;

EID: 77956942386     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12767359113767     Document Type: Article

References (43)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. CA. Cancer J. Clin. 58:71-96; 2008.
2. Ferlay, J.; Autier, P.; Boniol, M.; Heanue, M.; Colombet, M.; Boyle, P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18:581-592; 2007.
3. Bourguignon, L. Y.; Zhu, H.; Shao, L.; Zhu, D.; Chen, Y. W. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell. Motil. Cytoskeleton 43:269-287; 1999.
4. Nishimura, Y.; Itoh, K.; Yoshioka, K.; Tokuda, K.; Himeno, M. Overexpression of ROCK in human breast cancer cells: Evidence that ROCK activity mediates intracellular membrane traffic of lysosomes. Pathol. Oncol. Res. 9:83-95; 2003.
5. Ying, H.; Biroc, S. L.; Li, W. W.; Alicke, B.; Xuan, J. A.; Pagila, R.; Ohashi, Y.; Okada, T.; Kamata, Y.; Dinter, H. Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Mol. Cancer Ther. 5:2158-2164; 2006.
6. Burbelo, P.; Wellstein, A.; Pestell, R. G. Altered Rho GTPase signaling pathways in breast cancer cells. Breast Cancer Res. Treat. 84:43-48; 2004.
7. Lin, M.; van Golen, K. L. Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res. Treat. 84:49-60; 2004.
8. Shi, J.; Wei, L. Rho kinase in the regulation of cell death and survival. Arch. Immunol. Ther. Exp. (Warsz.) 55:61-75; 2007.
9. Vega, F. M.; Ridley, A. J. Rho GTPases in cancer cell biology. FEBS Lett. 582:2093-2101; 2008.
10. Katoh, K.; Kano, Y.; Ookawara, S. Rho-kinase dependent organization of stress fibers and focal adhesions in cultured fibroblasts. Genes Cells 12:623-638; 2007. (Pubitemid 46824960)
11. Itoh, K.; Yoshioka, K.; Akedo, H.; Uehata, M.; Ishizaki, T.; Narumiya, S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat. Med. 5:221-225; 1999.
12. Abe, H.; Kamai, T.; Tsujii, T.; Nakamura, F.; Mashidori, T.; Mizuno, T.; Tanaka, M.; Tatsumiya, K.; Furuya, N.; Masuda, A.; Yamanishi, T.; Yoshida, K. Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma. Biomed. Res. 29:155-161; 2008.
13. Somlyo, A. V.; Bradshaw, D.; Ramos, S.; Murphy, C.; Myers, C. E.; Somlyo, A. P. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem. Biophys. Res. Commun. 269:652-659; 2000.
14. Nakajima, M.; Katayama, K.; Tamechika, I.; Hayashi, K.; Amano, Y.; Uehata, M.; Goto, N.; Kondo, T. WF-536 inhibits metastatic invasion by enhancing the host cell barrier and inhibiting tumour cell motility. Clin. Exp. Pharmacol. Physiol. 30:457-463; 2003.
15. Nakajima, M.; Hayashi, K.; Katayama, K.; Amano, Y.; Egi, Y.; Uehata, M.; Goto, N.; Kondo, T. Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions. Eur. J. Pharmacol. 459:113-120; 2003.
16. Ogawa, T.; Tashiro, H.; Miyata, Y.; Ushitora, Y.; Fudaba, Y.; Kobayashi, T.; Arihiro, K.; Okajima, M.; Asahara, T. Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model. Am. J. Transplant. 7:347-355; 2007.
17. Doughty, J. C. A review of the BIG results: The Breast International Group 1-98 trial analyses. Breast 17(Suppl. 1):S9-S14; 2008.
18. Rabbani, S. A.; Mazar, A. P. Evaluating distant metastases in breast cancer: From biology to outcomes. Cancer Metastasis Rev. 26:663-674; 2007.
19. Elder, E. E.; Kennedy, C. W.; Gluch, L.; Carmalt, H. L.; Hanu, N. C.; Joseph, M. G.; Donellan, M. J.; Molland, J. G.; Gillett, D. J. Patterns of breast cancer relapse. Eur. J. Surg. Oncol. 32:922-927; 2006.
20. Bussard, K. M.; Gay, C. V.; Mastro, A. M. The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Rev. 27:41-55; 2008.
21. Hodgson, S. V.; Morrison, P. J.; Irving, M. Breast cancer genetics: Unsolved questions and open perspectives in an expanding clinical practice. Am. J. Med. Genet. C Semin. Med. Genet. 129:56-64; 2004.
22. Miller, S. A.; Dykes, D. D.; Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215; 1998.
23. Yamaguchi, H.; Kasa, M.; Amano, M.; Kaibuchi, K.; Hakoshima, T. Molecular mechanism for the regulation of Rho-kinase by dimerization and its inhibition by fasudil. Structure 14:589-600; 2006. (Pubitemid 43363491)
24. Doran, J. D.; Liu, X.; Taslimi, P.; Saadat, A.; Fox, T. New insights into the structure-function relationships of Rho-associated kinase: A thermodynamic and hydrodynamic study of the dimer-to-monomer transition and its kinetic implications. Biochem. J. 384:255-262; 2004. (Pubitemid 39656237)
25. Seasholtz, T. M.; Wessel, J.; Rao, F.; Rana, B. K.; Khandrika, S.; Kennedy, B. P.; Lillie, E. O.; Ziegler, M. G.; Smith, D. W.; Schork, N. J.; Brown, J. H.; O'Connor, D. T. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: Role of heredity. Hypertension 47:937-947; 2006.
26. Zhao, Q.; Wang, L.; Yang, W.; Chen, S.; Huang, J.; Fan, Z.; Li, H.; Lu, X.; Gu, D. Interactions among genetic variants from contractile pathway of vascular smooth muscle cell in essential hypertension susceptibility of Chinese Han population. Pharmacogenet. Genomics 18:459-466; 2008. (Pubitemid 351769914)
27. Simpson, K. J.; Dugan, A. S.; Mercurio, A. M. Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res. 64:8694-8701; 2004.
28. Rattan, R.; Giri, S.; Singh, A. K.; Singh, I. Rho/ROCK pathway as a target of tumor therapy. J. Neurosci. Res. 83:243-255, 2006.
29. Kleer, C. G.; Griffith, K. A.; Sabel, M. S.; Gallagher, G.; van Golen, K. L.; Wu, Z. F.; Merajver, S. D. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Res. Treat. 93:101-110; 2005.
30. Sahai, E.; Marshall, C. J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis . Nat. Cell Biol. 5: 711-719; 2003.
31. Yamazaki, D.; Kurisu, S.; Takenawa, T. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96:379-386; 2005. (Pubitemid 41179738)
32. Wyckoff, J. B.; Pinner, S. E.; Gschmeissner, S.; Condeelis, J. S.; Sahai, E. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr. Biol. 16:1515-1523; 2006.
33. Han, Z.; Xu, G.; Zhou, J.; Xing, H.; Wang, S.; Wu, M.; Zhang, Y.; Lu, Y.; Ma, D. Inhibition of motile and invasive properties of ovarian cancer cells by ASODN against Rho-associated protein kinase. Cell Commun. Adhes. 12: 59-69; 2005.
34. Kamai, T.; Tsujii, T.; Arai, K.; Takagi, K.; Asami, H.; Ito, Y.; Oshima, H. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin. Cancer Res. 9:2632-2641; 2003.
35. Anderson, J. M.; Balda, M. S.; Fanning, A. S. The structure and regulation of tight junctions. Curr. Opin. Cell Biol. 5:772-778; 1993.
36. Martin, T. A.; Jiang, W. G. Tight junctions and their role in cancer metastasis. Histol. Histopathol. 16:1183-1195; 2001.
37. Li, B.; Zhao, W. D.; Tan, Z. M.; Fang, W. G.; Zhu, L.; Chen, Y. H. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett. 580:4252-4260; 2006.
38. Saito, H.; Minamiya, Y.; Saito, S.; Ogawa, J. Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation. J. Leukoc. Biol. 72:829-836; 2002.
39. Slamon, D. J.; Clark, G. M.; Wong, S. G.; Levin, W. J.; Ullrich, A.; McGuire, W. L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182; 1987.
40. Perez, E. A.; Baweja, M. HER2-positive breast cancer: Current treatment strategies. Cancer Invest. 26:545-552; 2008. (Pubitemid 351918580)
41. Hedjazifar, S.; Jenndahl, L. E.; Shimokawa, H.; Baeckström, D. PKB mediates c-erbB2-induced epithelial β1 integrin conformational inactivation through Rho-independent F-actin rearrangements. Exp. Cell Res. 307:259-275; 2005.
42. Fu, X. D.; Giretti, M. S.; Baldacci, C.; Garibaldi, S.; Flamini, M.; Sanchez, A. M.; Gadducci, A.; Genazzani, A. R.; Simoncini, T. Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS ONE 3:e2790; 2008.
43. Giretti, M. S.; Fu, X. D.; De Rosa, G.; Sarotto, I.; Baldacci, C.; Garibaldi, S.; Mannella, P.; Biglia, N.; Sismondi, P.; Genazzani, A. R.; Simoncini, T. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS ONE 3: e2238; 2008.